Status:
COMPLETED
Magnesium Administration in Liver Transplantation and Reperfusion Injury
Lead Sponsor:
The Catholic University of Korea
Conditions:
Living Donor Liver Transplantation
Reperfusion Injury
Eligibility:
All Genders
20-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effect of intravenous magnesium infusion before reperfusion with employing some clinical parameters including blood lactate levels, because the intraoperat...
Detailed Description
Clinically significant hemodynamic deterioration occurs immediately after reperfusion of the grafted liver by unclamping of the portal vein. Profound hypotension, bradycardia, systemic vasodilation, a...
Eligibility Criteria
Inclusion
- adult patients scheduled for elective living donor liver transplantation
Exclusion
- pediatric patients
- re-transplantation
- renal dysfunction
- cardiovascular disease
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00994981
Start Date
September 1 2007
End Date
October 1 2008
Last Update
November 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Catholic University of Korea, Seoul Saint Mary's Hospital
Seoul, South Korea, 137-040